Neuromyelitis Optica Spectrum Disorder (NMOSD)

Diagnosis and management of NMOSD.

Reviewed by Dr Kola Tytler MBBS CertHE MBA MRCGP (General Practitioner)
Last reviewed: 21 October 2025
NeurologyOphthalmology

Clinical Guidelines

NICE Guidance: Ravulizumab for treating AQP4 antibody-positive neuromyelitis optica spectrum disorder
National
Clinical practice guidelines for multiple sclerosis, neuromyelitis optica spectrum disorder, and myelin oligodendrocyte glycoprotein antibody-associated disease (Japanese Society of Neurology, 2017)
Local
International consensus diagnostic criteria for neuromyelitis optica spectrum disorders
Local
International Delphi Consensus on the Management of AQP4-IgG+ Neuromyelitis Optica Spectrum Disorder
Local
Latin American consensus recommendations for management and treatment of neuromyelitis optica spectrum disorder (NMOSD)
Local
Saudi consensus recommendations on the management of neuromyelitis optica spectrum disorder (NMOSD)
Local